1163 - Testing for gastric cancer for access to trastuzumab

Page last updated: 13 July 2016

Application Detail



Description of Medical Service

In-situ hybridisation (ISH) for PBS listing of trastuzumab.

Description of Medical Condition

Previously untreated human epidermal growth factor receptor 2 (HER2) positive inoperable locally advanced or metastatic gastric or gastro-oesophageal cancer.

Reason for Application

New MBS item

Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form


PICO Confirmation

14 - 15 September 2011
Final Decision Analytic Protocol (DAP) (PDF 542 KB)
Final Decision Analytic Protocol (DAP) (Word 1319 KB)

Assessment Report


Public Summary Document

Public Summary Document (PDF 697 KB)
Public Summary Document (Word 756 KB)

Meetings for this Application


7 July 2011


11 - 12 October 2012


29 - 30 November 2012